GenBioPro, the manufacturer of generic mifepristone, which is approved by the US Food and Drug Administration (FDA) as part of a two-drug regimen for the termination of early pregnancy, sued to block West Virginia’s ban on abortion and associated restrictions that limit access to the medication, in what has been described the “opening salvo” of post-Dobbs litigation. Donate now to support the litigation efforts.
We defend positive policies from right-wing attacks in the courts.
We work at all levels to counter negative trends and support positive change.
We advance progressive legal theory through coordinated partner engagement.